Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
C2 Pharma
CAI
DPS Group
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Oncology
373 Articles Available
1
16
Can't find what you're looking for? Try our
advanced search
.
Theranostics
Theranostic Manufacturing Solutions
PAO-08-022-CL-07
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
PAO-05-22-R250-09
Oncology
Fighting Cancer and Supporting Patients
PAO-04-22-R250-13
Oncology Collaboration
Tegmine Therapeutics Announces Collaboration with Alloy Therapeutics to Advance Solid Tumor Treatment
PR-M04-22-03
Cancer Genetics
Developing RNA Screening for Cancer Diagnosis
PAO-04-22-R250-08
Oncology
Changing the Paradigm of Cancer Drug Discovery and Development with Plants
PAO-02-022-CL-02
Oncology
Fighting Cancer by Focusing on Nuclear Export
PAO-02-022-CL-06
Oncolytic Viruses
Best Practices For Oncolytic Virus Design, Development, and Manufacturing
PAO-02-022-CL-17
Cancer Diagnostics
Envisioning a New Cancer Diagnostic and Therapeutic Platform
PAO-02-22-R250-11
Data Connectivity
Discussing the Advancements in Oncology
PATV-12-21-01
Decentralized Clinical Trials
How Can Oncology Trials Be Decentralized?
PAO-10-21-CL-16
Oncology Clinical Trials
Estimands in Oncology Trials
PAO-10-21-CL-07
Precision Medicine
Profiling Cancer Genetics to Enable Precision Therapies
585859020
Oncology Clinical Trials
Delivering the Full Value Chain for Oncology Clinical Trials
PAO-07-21-CL-09
Immuno-Oncology
Training the Immune System to Recognize Cancer Cells
PTV-07-21-CL-001
Antibody-Drug Conjugates
Accelerating ADC Development with Advanced Payload Intermediates
PAO-06-21-CL-11
Oncology
HEALED Consortium Successful in a €10.5M DTIF-Supported Program to Develop Groundbreaking New Therapies for Currently Incurable Cancers
PR-M04-21-031
Brain Cancer Diagnostics
Advancing Diagnostics to Address Brain Tumors
PAO-04-22-R221-16
Brain Tumors
Innovating in the Fight against Brain Tumors
PAO-04-22-R221-15
Personalized Oncology
Personalizing Cancer Treatment Recommendations
PAO-04-22-R221-04
Oncology Clinical Trials
Accelerating Oncology Clinical Research Remotely
PAO-04-21-CL-02
Natural Killer T cells
Combating Cancer and Other Diseases with Supercharged NKT Cells
PAP-Q4-20-CL-005
Fast Track
Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Pancreatic Cancer
PR-M11-20-012
Cancer Vaccine
Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program
PR-M11-20-009
1
16
»
